Engineered hybrid cardiac patches with multifunctional electronics for online monitoring and regulation of tissue function

Article metrics

Abstract

In cardiac tissue engineering approaches to treat myocardial infarction, cardiac cells are seeded within three-dimensional porous scaffolds to create functional cardiac patches. However, current cardiac patches do not allow for online monitoring and reporting of engineered-tissue performance, and do not interfere to deliver signals for patch activation or to enable its integration with the host. Here, we report an engineered cardiac patch that integrates cardiac cells with flexible, freestanding electronics and a 3D nanocomposite scaffold. The patch exhibited robust electronic properties, enabling the recording of cellular electrical activities and the on-demand provision of electrical stimulation for synchronizing cell contraction. We also show that electroactive polymers containing biological factors can be deposited on designated electrodes to release drugs in the patch microenvironment on demand. We expect that the integration of complex electronics within cardiac patches will eventually provide therapeutic control and regulation of cardiac function.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Schematics of the microelectronic cardiac patch concept.
Figure 2: Freestanding electronic mesh device.
Figure 3: Controlled release of biomolecules from the electronic device.
Figure 4: Biomaterial–electronics hybrid.
Figure 5: Tissue organization and function within the 3D electronic scaffold.
Figure 6: Remote control over the microECP function.

References

  1. 1

    Dvir, T., Timko, B. P., Kohane, D. S. & Langer, R. Nanotechnological strategies for engineering complex tissues. Nature Nanotech. 6, 13–22 (2011).

  2. 2

    Fleischer, S. et al. Spring-like fibers for cardiac tissue engineering. Biomaterials 34, 8599–8606 (2013).

  3. 3

    Chiu, L. L., Janic, K. & Radisic, M. Engineering of oriented myocardium on three-dimensional micropatterned collagen-chitosan hydrogel. Int. J. Artif. Organs 35, 237–250 (2012).

  4. 4

    Engelmayr, G. C. Jr et al. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nature Mater. 7, 1003–1010 (2008).

  5. 5

    Kim, D. H. et al. Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proc. Natl Acad. Sci. USA 107, 565–570 (2010).

  6. 6

    Radisic, M. et al. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng. 12, 2077–2091 (2006).

  7. 7

    Eschenhagen, T. et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J. 11, 683–694 (1997).

  8. 8

    Shevach, M., Maoz, B. M., Feiner, R., Shapira, A. & Dvir, T. Nanoengineering gold particle composite fibers for cardiac tissue engineering. J. Mater. Chem. B 1, 5210–5217 (2013).

  9. 9

    Fleischer, S. et al. Albumin fiber scaffolds for engineering functional cardiac tissues. Biotechnol. Bioeng. 111, 1246–1257 (2014).

  10. 10

    Bian, W., Jackman, C. P. & Bursac, N. Controlling the structural and functional anisotropy of engineered cardiac tissues. Biofabrication 6, 024109 (2014).

  11. 11

    Dvir, T. et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc. Natl Acad. Sci. USA 106, 14990–14995 (2009).

  12. 12

    Zimmermann, W. H. et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nature Med. 12, 452–458 (2006).

  13. 13

    Radisic, M. et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl Acad. Sci. USA 101, 18129–18134 (2004).

  14. 14

    Marsano, A. et al. The effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarction. Biomaterials 34, 393–401 (2013).

  15. 15

    Tian, B. et al. Macroporous nanowire nanoelectronic scaffolds for synthetic tissues. Nature Mater. 11, 986–994 (2012).

  16. 16

    Tian, B. et al. Three-dimensional, flexible nanoscale field-effect transistors as localized bioprobes. Science 329, 830–834 (2010).

  17. 17

    Duan, X., Fu, T. M., Liu, J. & Lieber, C. M. Nanoelectronics–biology frontier: from nanoscopic probes for action potential recording in live cells to three-dimensional cyborg tissues. Nano Today 8, 351–373 (2013).

  18. 18

    Cogan, S. F. Neural stimulation and recording electrodes. Annu. Rev. Biomed. Eng. 10, 275–309 (2008).

  19. 19

    Lampin, M., Warocquier, C., Legris, C., Degrange, M. & Sigot-Luizard, M. F. Correlation between substratum roughness and wettability, cell adhesion, and cell migration. J. Biomed. Mater. Res. 36, 99–108 (1997).

  20. 20

    Jensen, M., Hansen, P. B., Murdan, S., Frokjaer, S. & Florence, A. T. Loading into and electro-stimulated release of peptides and proteins from chondroitin 4-sulphate hydrogels. Eur. J. Pharm. Sci. 15, 139–148 (2002).

  21. 21

    Pillay, V. et al. A review of integrating electroactive polymers as responsive systems for specialized drug delivery applications. J. Biomed. Mater. Res. A 102, 2039–2054 (2014).

  22. 22

    Levesque, J. P., Hendy, J., Takamatsu, Y., Simmons, P. J. & Bendall, L. J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J. Clin. Invest. 111, 187–196 (2003).

  23. 23

    Aiuti, A., Webb, I. J., Bleul, C., Springer, T. & Gutierrez-Ramos, J. C. The chemokine SDF-1 is a chemoattractant for human CD34 + hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34 + progenitors to peripheral blood. J. Exp. Med. 185, 111–120 (1997).

  24. 24

    Leor, J., Amsalem, Y. & Cohen, S. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol. Ther. 105, 151–163 (2005).

  25. 25

    Wadhwa, R., Lagenaur, C. F. & Cui, X. T. Electrochemically controlled release of dexamethasone from conducting polymer polypyrrole coated electrode. J. Control. Release 110, 531–541 (2006).

  26. 26

    Tsurufuji, S., Sugio, K. & Takemasa, F. The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone. Nature 280, 408–410 (1979).

  27. 27

    Patil, S. D., Papadmitrakopoulos, F. & Burgess, D. J. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J. Control. Release 117, 68–79 (2007).

  28. 28

    Mond, H. G., Helland, J. R., Stokes, K., Bornzin, G. A. & McVenes, R. The electrode–tissue interface: the revolutionary role of steroid-elution. Pacing Clin. Electrophysiol. 37, 1232–1249 (2014).

  29. 29

    Kim, J. H. et al. Sulfated chitosan oligosaccharides suppress LPS-induced NO production via JNK and NF-κB inactivation. Molecules 19, 18232–18247 (2014).

  30. 30

    Zinger, B. & Miller, L. L. Timed release of chemicals from polypyrrole films. J. Am. Chem. Soc. 106, 6861–6863 (1984).

  31. 31

    Sivakumar, R., Anandh Babu, P. V. & Shyamaladevi, C. S. Protective effect of aspartate and glutamate on cardiac mitochondrial function during myocardial infarction in experimental rats. Chem. Biol. Interact. 176, 227–233 (2008).

  32. 32

    Fleischer, S. & Dvir, T. Tissue engineering on the nanoscale: lessons from the heart. Curr. Opin. Biotechnol. 24, 664–671 (2013).

  33. 33

    Pope, A. J., Sands, G. B., Smaill, B. H. & LeGrice, I. J. Three-dimensional transmural organization of perimysial collagen in the heart. Am. J. Physiol. Heart Circ. Physiol. 295, H1243–H1252 (2008).

  34. 34

    Zimmermann, W. H. et al. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 90, 223–230 (2002).

  35. 35

    Nunes, S. S. et al. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nature Methods 10, 781–787 (2013).

  36. 36

    Bursac, N. et al. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am. J. Physiol. 277, H433–H444 (1999).

  37. 37

    Iyer, R. K., Chiu, L. L., Reis, L. A. & Radisic, M. Engineered cardiac tissues. Curr. Opin. Biotechnol. 22, 706–714 (2011).

  38. 38

    Tandon, N. et al. Electrical stimulation systems for cardiac tissue engineering. Nature Protocols 4, 155–173 (2009).

  39. 39

    Kim, D. H., Ghaffari, R., Lu, N. & Rogers, J. A. Flexible and stretchable electronics for biointegrated devices. Annu. Rev. Biomed. Eng. 14, 113–128 (2012).

  40. 40

    Kim, D. H. & Rogers, J. A. Stretchable electronics: materials strategies and devices. Adv. Mater. 20, 4887–4892 (2008).

  41. 41

    Rogers, J. A., Someya, T. & Huang, Y. Materials and mechanics for stretchable electronics. Science 327, 1603–1607 (2010).

  42. 42

    Xu, L. et al. Materials and fractal designs for 3D multifunctional integumentary membranes with capabilities in cardiac electrotherapy. Adv. Mater. 27, 1731–1737 (2015).

  43. 43

    Zhang, Y., Ouyang, H., Lim, C. T., Ramakrishna, S. & Huang, Z. M. Electrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds. J. Biomed. Mater. Res. 72, 156–165 (2005).

  44. 44

    Shevach, M., Fleischer, S., Shapira, A. & Dvir, T. Gold nanoparticle-decellularized matrix hybrids for cardiac tissue engineering. Nano Lett. 14, 5792–5796 (2014).

Download references

Acknowledgements

T.D. acknowledges support from European Research Council (ERC) Starting Grant 637943, the European Union FP7 programme (Marie Curie, CIG), an Alon Fellowship, the Slezak Foundation, and the Israeli Science Foundation (700/13). R.F. thanks the Marian Gertner Institute for Medical Nanosystems Fellowship. The work is part of the doctoral thesis of R.F. at Tel Aviv University. We would like to thank T. Yoetz and N. Noor for technical assistance.

Author information

R.F. and T.D. conceived the idea and designed the experiments. R.F. performed all experiments. L.E. assisted in microfabrication and characterization of the electronics. S.F. and A.S. performed cell culture work. M.M. and I.G. assisted in drug release experiments. Y.S.-D. analysed data. R.F. and T.D. wrote the manuscript. The study was directed by T.D.

Correspondence to Tal Dvir.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

Supplementary Information (PDF 3141 kb)

Supplementary Movie 1

Supplementary Movie 1 (AVI 1048 kb)

Supplementary Movie 2

Supplementary Movie 2 (AVI 1085 kb)

Supplementary Movie 3

Supplementary Movie 3 (AVI 1100 kb)

Supplementary Movie 4

Supplementary Movie 4 (AVI 4041 kb)

Supplementary Movie 5

Supplementary Movie 5 (AVI 4588 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Feiner, R., Engel, L., Fleischer, S. et al. Engineered hybrid cardiac patches with multifunctional electronics for online monitoring and regulation of tissue function. Nature Mater 15, 679–685 (2016) doi:10.1038/nmat4590

Download citation

Further reading